Sector: Pharmaceuticals & Biotechnology

Small Cap

Goldline Pharmaceutical Share Price

Q: What is the Market Capitalization of Goldline Pharmaceutical Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 21 August 2026, the market cap for Goldline Pharmaceutical Ltd. is approximately ₹ 39.3 Cr.

Q: What are the PE and PB ratios for Goldline Pharmaceutical Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Goldline Pharmaceutical Ltd. is 9.6, and the Price-to-Book (PB) ratio is 3.

Q: What is the 52-Week High and Low for Goldline Pharmaceutical Ltd.?

Over the past 52 weeks, the highest price reached by Goldline Pharmaceutical Ltd. shares was ₹ 60, and the lowest price was ₹ 33.

Q: Who are the major shareholders of Goldline Pharmaceutical Ltd.?

Significant shareholdings in Goldline Pharmaceutical Ltd. typically include entities such as: Promoter Public Other Institutions FII (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Goldline Pharmaceutical Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Goldline Pharmaceutical Ltd. is often compared with other major players such as Bio Medica Laboratories, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Q: What is the shareholding pattern for Goldline Pharmaceutical Ltd.?

As per the filings for the quarter ending Quarter, the approximate shareholding pattern for Goldline Pharmaceutical Ltd. is: Promoters: Promoter Holding (%)% Domestic Institutional Investors (DII): Holding (%)% Foreign Institutional Investors (FII): Holding (%)% Others (including Public): Holding (%)%

GLPL

₹40.95

-0.02(-0.05%)

21st Aug 2026 | 3:25 PM

NSE :

Open Free Demat Account

Goldline Pharmaceutical Performance

Price Movement

N/A

₹38.70

₹39.66

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹39.66

Low₹38.70

Open at₹39.66

Prev Close₹40.97

Volumes84.00 K

Avg Price₹38.98

Lower Circuit₹31.12

Upper Circuit₹46.68

Historical Performance

3M High₹51.78

3M Low₹33.00

1 Yr High₹60.00

1 Yr Low₹33.00

3 Yr High₹60.00

3 Yr Low₹33.00

5 Yr High₹60.00

5 Yr Low₹33.00

Summary

As of 25-08-2026 03:49, Goldline Pharmaceutical Ltd. share price today is ₹0, with a change of ₹-40.97 (-100.00%) from the previous close of ₹40.97. The stock opened at ₹39.66 and traded between ₹38.7 and ₹39.66, with a total traded volume of 84000 shares. The company has a market capitalization of ₹39.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹60 and ₹33, respectively.

Goldline Pharmaceutical Ltd. valuation metrics include a P/E ratio of 9.6, and book value of ₹3.00. Profitability indicators show ROE of 33.08%.

Goldline Pharmaceutical Ltd. technical indicators include Day RSI at 49.83, Day MFI at 47.29, Day ADX at 14.6. Additional indicators include Commodity Channel Index (CCI) at 31 and Williams %R at -64.19. Momentum indicators show Day MACD at -0.29, Day MACD Signal Line at -0.5, DayATR at 1.93. Rate of Change indicators for Goldline Pharmaceutical Ltd. include ROC21 at 1.19.

Exponential moving averages include EMA5 at ₹40.6, EMA10 at ₹40.5, EMA12 at ₹40.4, EMA20 at ₹40.5, EMA26 at ₹40.7, EMA50 at ₹42.3. Simple moving averages include SMA5 at ₹40.3, SMA10 at ₹40.7, SMA20 at ₹40.2, SMA30 at ₹40.2, SMA50 at ₹41.8.

Support levels for Goldline Pharmaceutical are placed at First Support ₹40.30, Second Support ₹39.62, Third Support ₹39.25. Resistance levels are seen at First Resistance ₹41.35, Second Resistance ₹41.72, Third Resistance ₹42.40. Goldline Pharmaceutical Ltd. shareholding pattern shows promoter holding at 57.29%, FII holding at 5.16%, DII holding at 0%, public holding at 29.74%.

Goldline Pharmaceutical Fundamentals

Market Cap

Low in industry

39.30 Cr.

PE Ratio (TTM)

Below industry Median

9.60

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

0% decr over last year

33.08

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

Above industry Median

MFI

MFI is mid-range

47.29

RSI

RSI is mid-range

49.83

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

Goldline Pharmaceutical Financials

Data not available for chart

Indicator
No Record Found

Goldline Pharmaceutical Technicals

Goldline Pharmaceutical Ltd. EMA & SMA

₹40.95

-0.24 (-0.58%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹40.6

Day EMA10 ₹40.5

Day EMA12 ₹40.4

Day EMA20 ₹40.5

Day EMA26 ₹40.7

Day EMA50 ₹42.3

Goldline Pharmaceutical Support and Resistance

Resistance

First Resistance₹41.35

Second Resistance₹41.72

Third Resistance₹42.40

Support

First Support₹40.30

Second Support₹39.62

Third Support₹39.25

Technical Indicators

Day RSI49.83

Day MFI47.29

Day ADX14.60

Day Commodity Channel Index31.00

William-64.19

Day MACD-0.29

Day MACD Signal Line-0.50

Day ATR1.93

Day ROC125-

Day ROC211.19

Goldline Pharmaceutical Shareholding Pattern

Held By
Promoter
FII
DII
Public

Goldline Pharmaceutical Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	87 K	2.1 L	41.43%
Week	90.75 K	1.23 L	73.78%
1 Month	51.33 K	84 K	61.11%
6 Month	52.24 K	65.03 K	80.33%

Goldline Pharmaceutical SWOT Analysis

Strengths9

Weakness8

Opportunity0

Threats0

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Volume Shockers

Insiders bought stocks

Goldline Pharmaceutical Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Goldline Pharmaceutical Stock Comparison

Financials	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.
Price (₹)	₹526.25	₹151.20	₹286	₹43.80	₹6.55
% Change	-2.70%	0.00%	0.00%	4.99%	4.97%
Revenue TTM (₹ Cr)	₹526.28	-	-	₹1.93	₹69.99
Net Profit TTM (₹ Cr)	₹20.77	-	-	₹-0.34	₹-176.47
PE TTM	115.10	10.20	40.90	-76.30	-0.30
1 Year Return	37.97			855.56	524
ROCE	3.56	-	-	-	-56.37

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 296.40

+2.00%

AMANTA

Amanta Healthcare Ltd.

₹ 205.20

+4.81%

AHCL

Anlon Healthcare Ltd.

₹ 15.46

+8.26%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 93.30

-2.81%

APL

Asston Pharmaceuticals Ltd.

₹ 86.00

+1.74%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 518.70

-3.29%

ASTONEALAB

Astonea Labs Ltd.

₹ 278.00

-0.36%

AMWILL

Amwill Health Care Ltd.

₹ 43.50

+0.00%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 100.52

+4.99%

SHELTER

Shelter Pharma Ltd.

₹ 34.00

+6.25%

TLL

Trident Lifeline Ltd.

₹ 272.60

-3.49%

DPL

Dipna Pharmachem Ltd.

₹ 5.90

-7.81%

ACHYUT

Achyut Healthcare Ltd.

₹ 7.00

+0.00%

SIGACHI

Sigachi Industries Ltd.

₹ 30.45

+1.33%

WINDLAS

Windlas Biotech Ltd.

₹ 988.00

-0.56%

VINEETLAB

Vineet Laboratories Ltd.

₹ 37.00

-2.14%

CHCL

Cian Healthcare Ltd.

₹ 10.02

+4.92%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 628.00

+1.80%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.42

+7.69%

ZIMLAB

Zim Laboratories Ltd.

₹ 124.16

-0.70%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1469.95

+6.29%

MEDICO

Medico Remedies Ltd.

₹ 42.09

-1.31%

SGRL

Shree Ganesh Remedies Ltd.

₹ 516.50

+1.99%

FAQ's on GLPL

What is the Market Capitalization of Goldline Pharmaceutical Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 21 August 2026, the market cap for Goldline Pharmaceutical Ltd. is approximately ₹ 39.3 Cr.

What are the PE and PB ratios for Goldline Pharmaceutical Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Goldline Pharmaceutical Ltd. is 9.6, and the Price-to-Book (PB) ratio is 3.

What is the 52-Week High and Low for Goldline Pharmaceutical Ltd.?

Over the past 52 weeks, the highest price reached by Goldline Pharmaceutical Ltd. shares was ₹ 60, and the lowest price was ₹ 33.

Who are the major shareholders of Goldline Pharmaceutical Ltd.?

Significant shareholdings in Goldline Pharmaceutical Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Goldline Pharmaceutical Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Goldline Pharmaceutical Ltd. is often compared with other major players such as Bio Medica Laboratories, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.